HC Wainwright reissued their buy rating on shares of OptiNose (NASDAQ:OPTN – Free Report) in a research note published on Monday, Benzinga reports. HC Wainwright currently has a $5.00 price target on the stock. HC Wainwright also issued estimates for OptiNose’s Q1 2024 earnings at ($0.11) EPS, Q3 2024 earnings at ($0.06) EPS, Q4 2024 […]
HC Wainwright began coverage on shares of OptiNose (NASDAQ:OPTN – Get Free Report) in a report issued on Monday, Briefing.com reports. The firm set a “buy” rating and a $5.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 163.85% from the company’s previous close. OptiNose Stock Up 1.9 […]
OptiNose, Inc. (NASDAQ:OPTN – Get Free Report) CEO Ramy A. Mahmoud sold 11,114 shares of the firm’s stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $1.15, for a total value of $12,781.10. Following the sale, the chief executive officer now directly owns 509,728 shares in the […]
OptiNose, Inc. (NASDAQ:OPTN – Get Free Report) CEO Ramy A. Mahmoud sold 11,114 shares of the firm’s stock in a transaction on Monday, December 18th. The stock was sold at an average price of $1.15, for a total value of $12,781.10. Following the sale, the chief executive officer now directly owns 509,728 shares of the […]
OptiNose, Inc. (NASDAQ:OPTN – Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 4,550,000 shares, a growth of 23.3% from the August 31st total of 3,690,000 shares. Based on an average trading volume of 400,600 shares, the […]